0
     

Report Added
Report already added
Metagenomic Sequencing Market by Product & Services (Reagent, Consumables, Instrument), Workflow (Sample Preparation, Sequencing), Technology (16S rRNA, Shotgun, Whole-genome), Application (Drug Discovery, Diagnostic) - Global Forecast to 2027

Metagenomic Sequencing Market by Product & Services (Reagent, Consumables, Instrument), Workflow (Sample Preparation, Sequencing), Technology (16S rRNA, Shotgun, Whole-genome), Application (Drug Discovery, Diagnostic) - Global Forecast to 2027

The metagenomic sequencing market is expected to reach USD 4.3 billion by 2027 from USD 1.9 billion in 2022, at a CAGR of 18.4% during the forecast period. Growth in the metagenomic sequencing market is mainly driven by continuous technological innovations in NGS platforms, increasing initiatives and funding from government & private bodies for large-scale sequencing projects, declining costs of genome sequencing, and the significant applications of metagenomics in various fields.

“By technology segment, the shotgun metagenomic sequencing segment accounted for the fastest-growing segment of the metagenomic sequencing market”

Based on technology, the metagenomic sequencing market is segmented into 16S rRNA sequencing, shotgun metagenomic sequencing, whole-genome sequencing & de novo assembly, and metatranscriptomics. The shotgun metagenomic sequencing segment is estimated to grow at the highest CAGR during the forecast period. This can be attributed to its advantages over other techniques, the growing adoption of shotgun metagenomic sequencing among researchers and healthcare professionals, and the increasing number of metagenomic sequencing-based research activities.

“By workflow segment, the sample processing & library preparation segment accounted for the largest share of the metagenomic sequencing market”

Based on workflow, the market has been segmented into sample processing & library preparation, sequencing, and data processing & analysis. The sample processing & library preparation segment accounted for the largest share of the metagenomic sequencing market in 2021. The large share of this segment can be attributed to the growing number of metagenome sequencing research projects being conducted, the availability of technologically advanced and robust sample processing and library preparation assay kits, and the demand for efficient library preparation products.

“Asia Pacific: The fastest-growing region in the metagenomic sequencing market.”

The market in the Asia Pacific is expected to register the highest growth rate during the forecast period, primarily due to the increasing financial support from public as well as private agencies, the increasing number of NGS-based research projects, increasing awareness about precision medicine, and the rising prevalence of chronic diseases.

“North America: the largest share of the metagenomic sequencing market”

North America accounted for the largest share of the metagenomic sequencing market in 2021. Factors such as the increasing applications of metagenomics in diagnostics and genomics research, the availability of research funding, and the development of NGS data analysis solutions are driving the growth of the metagenomic sequencing market in North America.

Breakdown of primaries
The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs.

The break-up of the primaries is as follows:
•By Respondent– Supply Side- 70%, Demand Side-30%
•By Designation— CXOs and Directors- 30%, Executives - 25%, Mangers - 45%
•By Region— North America - 40%, Europe - 25%, APAC – 20%, LATAM- 10% , MEA- 5%

Prominent players in the metagenomic sequencing market include Illumina Inc. (US), Thermo Fisher Scientific lnc. (US), QIAGEN N.V. (Netherlands), PerkinElmer, Inc. (US), Oxford Nanopore Technologies (UK), Pacific Biosciences (US), BGI group (China), Psomagen Inc. (South Korea), Eurofins Scientific (Luxembourg), Zymo Research Corporation (US), Tecan Trading AG (Switzerland), Integragen SA (France), Microsynth AG (Switzerland), DNAStar Inc. (US), Brooks Automation, Inc. (US), and Novogene Co., Ltd. (China), Osmosis, INC. (US), Genexa AG. (Switzerland), Varigen Biosciences (US), Veritas Genetics (US), SinGENE (Singapore), Intact Genomics, Inc., Metagenomi (US), Computomics (Germany), and IDbyDNA Inc. (US).

Research Coverage:
The report segments the metagenomic sequencing market based on region (the Asia Pacific, Europe, North America, Latin America, and the Middle East & Africa), by Workflow (Sample Preparation, Sequencing, Data Processing and Analysis), by Product and Services (Instruments, Reagents and Consumables, Analysis and Data Interpretation Solutions, Metagenomic Sequencing Services), by Technology (Shotgun Metagenomic Sequencing, 16s Rrna Sequencing, Whole-Genome Sequencing and De Novo Assembly, Metatranscriptomics), by Application (Ecological and Environmental Metagenomics, Clinical Diagnostic Metagenomics, Drug Discovery Metagenomics, Soil Microbiome, Industrial Applications [Energ, Bioremediation, Other Industrial Application], Veterinary Metagenomics, Other Metagenomic Applications). The report also provides a comprehensive review of market drivers, restraints opportunities, challenges and trends in the metagenomic sequencing market.

Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the metagenomic sequencing market and provides them information on key market drivers, restraints, challenges, and opportunities.
Table of Contents

1INTRODUCTION30
1.1OBJECTIVES OF THE STUDY30
1.2MARKET DEFINITION30
1.2.1INCLUSIONS & EXCLUSIONS OF THE STUDY31
1.3MARKET SCOPE32
1.3.1MARKETS COVERED32
FIGURE 1METAGENOMIC SEQUENCING MARKET SEGMENTATION32
1.3.2YEARS CONSIDERED FOR THE STUDY33
1.4CURRENCY33
1.5LIMITATIONS33
1.6STAKEHOLDERS34
1.7SUMMARY OF CHANGES34
2RESEARCH METHODOLOGY35
2.1RESEARCH DATA35
FIGURE 2RESEARCH DESIGN35
2.1.1SECONDARY DATA36
2.1.2PRIMARY DATA37
FIGURE 3PRIMARY SOURCES37
FIGURE 4METAGENOMIC SEQUENCING MARKET: BREAKDOWN OF PRIMARIES38
2.1.2.1Key industry insights39
2.2MARKET SIZE ESTIMATION39
FIGURE 5MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS, 202139
FIGURE 6MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP (SUPPLY SIDE) – COLLECTIVE REVENUE OF ALL METAGENOMIC SEQUENCING
PRODUCTS & SERVICES40
FIGURE 7METAGENOMIC SEQUENCING MARKET: CAGR PROJECTIONS, 2022–202742
FIGURE 8METAGENOMIC SEQUENCING MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES42
2.3MARKET BREAKDOWN AND DATA TRIANGULATION44
FIGURE 9DATA TRIANGULATION METHODOLOGY44
2.4RESEARCH LIMITATIONS45
2.5GROWTH RATE ASSUMPTIONS45
2.6RISK ANALYSIS45

3EXECUTIVE SUMMARY46
FIGURE 10METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE,
2022 VS. 2027 (USD MILLION)46
FIGURE 11METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 202147
FIGURE 12METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION)48
FIGURE 13METAGENOMIC SEQUENCING MARKET SHARE, BY TECHNOLOGY, 202149
FIGURE 14GEOGRAPHICAL SNAPSHOT OF THE METAGENOMIC SEQUENCING MARKET50
4PREMIUM INSIGHTS51
4.1METAGENOMIC SEQUENCING MARKET OVERVIEW51
FIGURE 15TECHNOLOGICAL INNOVATIONS IN NGS PLATFORMS—A KEY FACTOR DRIVING GROWTH IN THE METAGENOMIC SEQUENCING MARKET51
4.2ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY
& COUNTRY (2021)52
FIGURE 1616S RRNA SEQUENCING TECHNOLOGY ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 202152
4.3METAGENOMIC SEQUENCING MARKET SHARE FOR INDUSTRIAL APPLICATIONS,
BY TYPE, 202153
FIGURE 17ENERGY APPLICATION SEGMENT DOMINATED THE MARKET IN 202153
5MARKET OVERVIEW54
5.1INTRODUCTION54
5.2MARKET DYNAMICS54
FIGURE 18METAGENOMIC SEQUENCING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES54
5.2.1DRIVERS55
5.2.1.1Continuous technological innovations in NGS platforms55
5.2.1.1.1iSeq 100 System55
5.2.1.1.2Ion GeneStudio S555
5.2.1.2Initiatives and funding from government & private bodies for large-scale sequencing projects55
TABLE 1GLOBAL SEQUENCING INITIATIVES56
5.2.1.3Declining costs of genome sequencing57
FIGURE 19COST OF HUMAN WHOLE-GENOME SEQUENCING, 2001–202057
5.2.1.4Significant applications of metagenomics in various fields57
5.2.2RESTRAINTS58
5.2.2.1End-user budget constraints in developing countries58
5.2.3OPPORTUNITIES59
5.2.3.1NGS data analysis using big data59
FIGURE 20DATA PRODUCTION DURING HUMAN WHOLE-GENOME SEQUENCING,
2001–201959
5.2.4CHALLENGES60
5.2.4.1Challenges associated with metagenomic NGS60
5.3IMPACT OF COVID-19 ON THE METAGENOMIC SEQUENCING MARKET61
5.4PORTER’S FIVE FORCES ANALYSIS63
TABLE 2METAGENOMIC SEQUENCING MARKET: PORTER’S FIVE FORCES ANALYSIS63
5.4.1THREAT OF NEW ENTRANTS63
5.4.2THREAT OF SUBSTITUTES63
5.4.3BARGAINING POWER OF SUPPLIERS63
5.4.4BARGAINING POWER OF BUYERS63
5.4.5COMPETITIVE RIVALRY AMONG EXISTING PLAYERS64
5.5VALUE CHAIN ANALYSIS64
FIGURE 21VALUE CHAIN ANALYSIS OF THE METAGENOMIC SEQUENCING MARKET: MANUFACTURING AND ASSEMBLY PHASES ADD MAXIMUM VALUE64
FIGURE 22VALUE CHAIN: METAGENOMIC SEQUENCING ANALYSIS WORKFLOW —MAXIMUM VALUE IS ADDED DURING THE SEQUENCING AND
ANALYSIS PHASES65
5.6ECOSYSTEM ANALYSIS66
FIGURE 23ECOSYSTEM ANALYSIS: METAGENOMIC SEQUENCING MARKET66
TABLE 3SUPPLY CHAIN ECOSYSTEM66
5.7PATENT ANALYSIS67
5.7.1TOP 10 GRANTED PATENT OWNERS IN THE LAST 20 YEARS67
5.7.2TOP 10 PLAYERS WITH THE HIGHEST NO. OF PATENT APPLICATIONS68
5.7.3LIST OF RECENT PATENTS68
5.8SUPPLY CHAIN ANALYSIS69
FIGURE 24DIRECT DISTRIBUTION—THE PREFERRED STRATEGY FOR PROMINENT COMPANIES70
5.9REGULATORY ANALYSIS70
5.9.1NORTH AMERICA70
5.9.1.1US70
TABLE 4US FDA: MEDICAL DEVICE CLASSIFICATION71
TABLE 5US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS71
5.9.1.2Canada72
5.9.2EUROPE72
5.9.3ASIA PACIFIC73
5.9.3.1China73
TABLE 6CHINA: CLASSIFICATION OF MEDICAL DEVICES73
5.9.3.2Japan73
5.9.3.3India73
5.9.4LATIN AMERICA74
5.9.5MIDDLE EAST74
5.10PRICING ANALYSIS74
TABLE 7AVERAGE SELLING PRICE OF NGS SYSTEMS (2020)74
5.11RANGES/SCENARIOS75
FIGURE 25DEPENDING ON HOW THE UNCERTAINTIES UNFOLD, WE SEE A SPECTRUM OF SCENARIOS FOR THE METAGENOMIC SEQUENCING MARKET75
5.12TRADE ANALYSIS75
5.12.1TRADE ANALYSIS FOR METAGENOMIC SEQUENCING MARKET75
TABLE 8IMPORT DATA FOR HS CODE 902780, BY COUNTRY,
2016-2020 (USD THOUSAND)75
TABLE 9EXPORT DATA FOR HS CODE 902780, BY COUNTRY,
2016-2020 (USD THOUSAND)76
5.13TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS76
5.14KEY CONFERENCES & EVENTS, 202277
TABLE 10METAGENOMIC SEQUENCING MARKET: DETAILED LIST OF CONFERENCES & EVENTS77
5.15KEY STAKEHOLDERS & BUYING CRITERIA78
TABLE 11INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP THREE APPLICATIONS (%)78
TABLE 12KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS78
6METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE79
6.1INTRODUCTION80
TABLE 13METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE,
2020–2027 (USD MILLION)80
6.2REAGENTS & CONSUMABLES80
6.2.1RISING ADOPTION OF METAGENOMIC SEQUENCING IS DRIVING
THE USE OF REAGENTS & CONSUMABLES80
TABLE 14METAGENOMIC SEQUENCING REAGENTS & CONSUMABLES MARKET,
BY REGION, 2020–2027 (USD MILLION)81
TABLE 15NORTH AMERICA: METAGENOMIC SEQUENCING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)81
TABLE 16EUROPE: METAGENOMIC SEQUENCING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)81
TABLE 17APAC: METAGENOMIC SEQUENCING REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)82
6.3INSTRUMENTS82
6.3.1LAUNCH OF ADVANCED NGS PLATFORMS WILL SUPPORT
THE GROWTH OF THIS SEGMENT82
TABLE 18METAGENOMIC SEQUENCING INSTRUMENTS MARKET, BY REGION,
2020–2027 (USD MILLION)83
TABLE 19NORTH AMERICA: METAGENOMIC SEQUENCING INSTRUMENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION)83
TABLE 20EUROPE: METAGENOMIC SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)83
TABLE 21APAC: METAGENOMIC SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)84
6.4SERVICES84
6.4.1TIME AND COST-EFFECTIVENESS OF OUTSOURCING NGS PROJECTS HAS DRIVEN THE DEMAND FOR SERVICES84
TABLE 22METAGENOMIC SEQUENCING SERVICES MARKET, BY REGION,
2020–2027 (USD MILLION)84
TABLE 23NORTH AMERICA: METAGENOMIC SEQUENCING SERVICES MARKET,
BY COUNTRY, 2020–2027 (USD MILLION)85
TABLE 24EUROPE: METAGENOMIC SEQUENCING SERVICES MARKET,
BY COUNTRY, 2020–2027 (USD MILLION)85
TABLE 25APAC: METAGENOMIC SEQUENCING SERVICES MARKET,
BY COUNTRY, 2020–2027 (USD MILLION)85
6.5ANALYSIS & DATA INTERPRETATION SOLUTIONS86
6.5.1LIMITED TECHNICAL KNOWLEDGE OF ADVANCED ANALYSIS SOLUTIONS AMONG END USERS TO HAMPER MARKET GROWTH86
TABLE 26METAGENOMIC SEQUENCING ANALYSIS & DATA INTERPRETATION SOLUTIONS MARKET, BY REGION, 2020–2027 (USD MILLION)86
TABLE 27NORTH AMERICA: METAGENOMIC SEQUENCING ANALYSIS & DATA INTERPRETATION SOLUTIONS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)86
TABLE 28EUROPE: METAGENOMIC SEQUENCING ANALYSIS & DATA INTERPRETATION SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)87
TABLE 29APAC: METAGENOMIC SEQUENCING ANALYSIS & DATA INTERPRETATION SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)87
7METAGENOMIC SEQUENCING MARKET, BY WORKFLOW88
7.1INTRODUCTION89
TABLE 30METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION)89
7.2SAMPLE PROCESSING & LIBRARY PREPARATION89
7.2.1AVAILABILITY OF TECHNOLOGICALLY ADVANCED SAMPLE PROCESSING AND LIBRARY PREPARATION ASSAY KITS IS DRIVING MARKET GROWTH89
TABLE 31SAMPLE PROCESSING & LIBRARY PREPARATION MARKET, BY REGION, 2020–2027 (USD MILLION)90
TABLE 32NORTH AMERICA: SAMPLE PROCESSING & LIBRARY PREPARATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)90
TABLE 33EUROPE: SAMPLE PROCESSING & LIBRARY PREPARATION MARKET,
BY COUNTRY, 2020–2027 (USD MILLION)91
TABLE 34APAC: SAMPLE PROCESSING & LIBRARY PREPARATION MARKET,
BY COUNTRY, 2020–2027 (USD MILLION)91
7.3SEQUENCING91
7.3.1SANGER SEQUENCING HAS BEEN SUPPLANTED BY NGS DUE TO ITS ADVANTAGES AND RAPIDITY91
TABLE 35SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)92
TABLE 36NORTH AMERICA: SEQUENCING MARKET, BY COUNTRY,
2020–2027 (USD MILLION)92
TABLE 37EUROPE: SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)92
TABLE 38APAC: SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)93
7.4DATA PROCESSING & ANALYSIS93
7.4.1NEED FOR SKILLED PERSONNEL TO OPERATE DATA PROCESSING AND ANALYTICS TOOLS HAS SLOWED MARKET GROWTH93
TABLE 39DATA PROCESSING & ANALYSIS MARKET, BY REGION,
2020–2027 (USD MILLION)94
TABLE 40NORTH AMERICA: DATA PROCESSING & ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)94
TABLE 41EUROPE: DATA PROCESSING & ANALYSIS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)94
TABLE 42APAC: DATA PROCESSING & ANALYSIS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)95
8METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY96
8.1INTRODUCTION97
TABLE 43METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)97
8.216S RRNA SEQUENCING97
8.2.116S RRNA SEQUENCING IS A COST-EFFECTIVE TECHNIQUE FOR THE IDENTIFICATION OF BACTERIAL STRAINS97
TABLE 4416S RRNA SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)98
TABLE 45NORTH AMERICA: 16S RRNA SEQUENCING MARKET, BY COUNTRY,
2020–2027 (USD MILLION)98
TABLE 46EUROPE: 16S RRNA SEQUENCING MARKET, BY COUNTRY,
2020–2027 (USD MILLION)99
TABLE 47APAC: 16S RRNA SEQUENCING MARKET, BY COUNTRY,
2020–2027 (USD MILLION)99
8.3SHOTGUN METAGENOMIC SEQUENCING99
8.3.1SHOTGUN METAGENOMIC SEQUENCING SEGMENT TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD99
TABLE 48SHOTGUN METAGENOMIC SEQUENCING MARKET, BY REGION,
2020–2027 (USD MILLION)100
TABLE 49NORTH AMERICA: SHOTGUN METAGENOMIC SEQUENCING MARKET,
BY COUNTRY, 2020–2027 (USD MILLION)100
TABLE 50EUROPE: SHOTGUN METAGENOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)101
TABLE 51APAC: SHOTGUN METAGENOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)101
8.4WHOLE-GENOME SEQUENCING & DE NOVO ASSEMBLY101
8.4.1WGS HELPS GENERATE ACCURATE REFERENCE GENOMES FOR MICROBIAL IDENTIFICATION101
TABLE 52WHOLE-GENOME SEQUENCING & DE NOVO ASSEMBLY MARKET, BY REGION, 2020–2027 (USD MILLION)102
TABLE 53NORTH AMERICA: WHOLE-GENOME SEQUENCING & DE NOVO ASSEMBLY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)102
TABLE 54EUROPE: WHOLE-GENOME SEQUENCING & DE NOVO ASSEMBLY MARKET,
BY COUNTRY, 2020–2027 (USD MILLION)103
TABLE 55APAC: WHOLE-GENOME SEQUENCING & DE NOVO ASSEMBLY MARKET,
BY COUNTRY, 2020–2027 (USD MILLION)103
8.5METATRANSCRIPTOMICS103
8.5.1METATRANSCRIPTOMICS HELPS IN THE UNDERSTANDING OF THE ACTIVE FUNCTIONAL PROFILE OF A MICROBIAL COMMUNITY103
TABLE 56METATRANSCRIPTOMICS MARKET, BY REGION, 2020–2027 (USD MILLION)104
TABLE 57NORTH AMERICA: METATRANSCRIPTOMICS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)105
TABLE 58EUROPE: METATRANSCRIPTOMICS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)105
TABLE 59APAC: METATRANSCRIPTOMICS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)105
9METAGENOMIC SEQUENCING MARKET, BY APPLICATION106
9.1INTRODUCTION107
TABLE 60METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION)107
9.2DRUG DISCOVERY107
9.2.1DRUG DISCOVERY ACCOUNTS FOR THE LARGEST SHARE OF THE METAGENOMIC SEQUENCING MARKET107
TABLE 61METAGENOMIC SEQUENCING MARKET FOR DRUG DISCOVERY, BY REGION, 2020–2027 (USD MILLION)108
TABLE 62NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2020–2027 (USD MILLION)108
TABLE 63EUROPE: METAGENOMIC SEQUENCING MARKET FOR DRUG DISCOVERY,
BY COUNTRY, 2020–2027 (USD MILLION)108
TABLE 64APAC: METAGENOMIC SEQUENCING MARKET FOR DRUG DISCOVERY,
BY COUNTRY, 2020–2027 (USD MILLION)109
9.3CLINICAL DIAGNOSTICS109
9.3.1ADVANTAGES OF METAGENOMIC NGS HAVE ENABLED WIDE APPLICATIONS IN DIAGNOSTICS109
TABLE 65METAGENOMIC SEQUENCING MARKET FOR CLINICAL DIAGNOSTICS,
BY REGION, 2020–2027 (USD MILLION)110
TABLE 66NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)110
TABLE 67EUROPE: METAGENOMIC SEQUENCING MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)110
TABLE 68APAC: METAGENOMIC SEQUENCING MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)111
9.4SOIL MICROBIOME APPLICATIONS111
9.4.1NORTH AMERICA SHOWS HIGH DEMAND FOR METAGENOMIC SEQUENCING IN SOIL MICROBIOME APPLICATIONS111
TABLE 69METAGENOMIC SEQUENCING MARKET FOR SOIL MICROBIOME APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)111
TABLE 70NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR SOIL MICROBIOME APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)112
TABLE 71EUROPE: METAGENOMIC SEQUENCING MARKET FOR SOIL MICROBIOME APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)112
TABLE 72APAC: METAGENOMIC SEQUENCING MARKET FOR SOIL MICROBIOME APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)112

9.5INDUSTRIAL APPLICATIONS113
TABLE 73METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS,
BY REGION, 2020–2027 (USD MILLION)113
TABLE 74NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)113
TABLE 75EUROPE: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)114
TABLE 76APAC: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)114
TABLE 77METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS,
BY TYPE, 2020–2027 (USD MILLION)114
9.5.1ENERGY115
9.5.1.1Declining fossil fuel reserves and growing energy needs will drive market growth115
TABLE 78METAGENOMIC SEQUENCING MARKET FOR ENERGY APPLICATIONS,
BY REGION, 2020–2027 (USD MILLION)115
TABLE 79NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR ENERGY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)115
TABLE 80EUROPE: METAGENOMIC SEQUENCING MARKET FOR ENERGY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)116
TABLE 81APAC: METAGENOMIC SEQUENCING MARKET FOR ENERGY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)116
9.5.2BIOREMEDIATION116
9.5.2.1Need to monitor pollutant impact and contamination will provide opportunities for metagenomic sequencing in bioremediation116
TABLE 82METAGENOMIC SEQUENCING MARKET FOR BIOREMEDIATION, BY REGION, 2020–2027 (USD MILLION)117
TABLE 83NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR BIOREMEDIATION, BY COUNTRY, 2020–2027 (USD MILLION)117
TABLE 84EUROPE: METAGENOMIC SEQUENCING MARKET FOR BIOREMEDIATION,
BY COUNTRY, 2020–2027 (USD MILLION)117
TABLE 85APAC: METAGENOMIC SEQUENCING MARKET FOR BIOREMEDIATION,
BY COUNTRY, 2020–2027 (USD MILLION)118
9.5.3OTHER INDUSTRIAL APPLICATIONS118
TABLE 86METAGENOMIC SEQUENCING MARKET FOR OTHER INDUSTRIAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)118
TABLE 87NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR OTHER INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)119
TABLE 88EUROPE: METAGENOMIC SEQUENCING MARKET FOR OTHER INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)119
TABLE 89APAC: METAGENOMIC SEQUENCING MARKET FOR OTHER INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)119
9.6ECOLOGICAL & ENVIRONMENTAL APPLICATIONS120
9.6.1METAGENOMIC SEQUENCING CAN HELP IDENTIFY INVASIVE AND ENDANGERED SPECIES120
TABLE 90METAGENOMIC SEQUENCING MARKET FOR ECOLOGICAL & ENVIRONMENTAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)120
TABLE 91NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR ECOLOGICAL & ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)120
TABLE 92EUROPE: METAGENOMIC SEQUENCING MARKET FOR ECOLOGICAL & ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)121
TABLE 93APAC: METAGENOMIC SEQUENCING MARKET FOR ECOLOGICAL & ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)121
9.7VETERINARY APPLICATIONS121
9.7.1DEMAND FOR RAPID AND ACCURATE PATHOGEN DIAGNOSIS IS SUPPORTING THE DEMAND FOR SEQUENCING121
TABLE 94METAGENOMIC SEQUENCING MARKET FOR VETERINARY APPLICATIONS,
BY REGION, 2020–2027 (USD MILLION)122
TABLE 95NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR VETERINARY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)122
TABLE 96EUROPE: METAGENOMIC SEQUENCING MARKET FOR VETERINARY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)122
TABLE 97APAC: METAGENOMIC SEQUENCING MARKET FOR VETERINARY APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)123
9.8OTHER APPLICATIONS123
TABLE 98METAGENOMIC SEQUENCING MARKET FOR OTHER APPLICATIONS,
BY REGION, 2020–2027 (USD MILLION)123
TABLE 99NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)124
TABLE 100EUROPE: METAGENOMIC SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)124
TABLE 101APAC: METAGENOMIC SEQUENCING MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION)124
10METAGENOMIC SEQUENCING MARKET, BY REGION125
10.1INTRODUCTION126
TABLE 102METAGENOMIC SEQUENCING MARKET, BY REGION,
2020–2027 (USD MILLION)126
10.2NORTH AMERICA126
FIGURE 26NORTH AMERICA: METAGENOMIC SEQUENCING MARKET SNAPSHOT127
TABLE 103NORTH AMERICA: METAGENOMIC SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)128
TABLE 104NORTH AMERICA: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2020–2027 (USD MILLION)128
TABLE 105NORTH AMERICA: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)128
TABLE 106NORTH AMERICA: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)129
TABLE 107NORTH AMERICA: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)129
TABLE 108NORTH AMERICA: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)130
10.2.1US130
10.2.1.1Well-established infrastructure and funding sources available for NGS-based small- and medium-sized research projects make the US the largest market in North America130
TABLE 109US: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION)131
TABLE 110US: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE,
2020–2027 (USD MILLION)131
TABLE 111US: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)132
TABLE 112US: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION)132
TABLE 113US: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)132
10.2.2CANADA133
10.2.2.1Increasing government initiatives and workshops to support growth in this market133
TABLE 114CANADA: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION)133
TABLE 115CANADA: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)134
TABLE 116CANADA: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)134
TABLE 117CANADA: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION)135
TABLE 118CANADA: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)135
10.3EUROPE135
TABLE 119EUROPE: METAGENOMIC SEQUENCING MARKET, BY COUNTRY,
2020–2027 (USD MILLION)136
TABLE 120EUROPE: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION)136
TABLE 121EUROPE: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)137
TABLE 122EUROPE: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)137
TABLE 123EUROPE: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION)138
TABLE 124EUROPE: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)138
10.3.1GERMANY139
10.3.1.1Germany has witnessed a significant increase in investments in next-generation technologies, making it the largest market in Europe139
TABLE 125GERMANY: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION)140
TABLE 126GERMANY: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)140
TABLE 127GERMANY: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)140
TABLE 128GERMANY: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION)141
TABLE 129GERMANY: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)141
10.3.2FRANCE141
10.3.2.1Government initiatives to support genomics research drive growth in the metagenomic sequencing market in France141
TABLE 130FRANCE: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION)142
TABLE 131FRANCE: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)142
TABLE 132FRANCE: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)143
TABLE 133FRANCE: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION)143
TABLE 134FRANCE: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)144
10.3.3UK144
10.3.3.1Favorable funding scenario for genomics research in the country to support the adoption of NGS144
TABLE 135UK: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION)145
TABLE 136UK: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE,
2020–2027 (USD MILLION)145
TABLE 137UK: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)146
TABLE 138UK: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION)146
TABLE 139UK: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)146
10.3.4REST OF EUROPE147
TABLE 140ROE: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION)147
TABLE 141ROE: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)148
TABLE 142ROE: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)148
TABLE 143ROE: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION)149
TABLE 144ROE: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)149
10.4ASIA PACIFIC149
FIGURE 27ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET SNAPSHOT150
TABLE 145ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY COUNTRY,
2020–2027 (USD MILLION)151
TABLE 146ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW, 2020–2027 (USD MILLION)151
TABLE 147ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)151
TABLE 148ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)152
TABLE 149ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)152
TABLE 150ASIA PACIFIC: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)153
10.4.1CHINA153
10.4.1.1Several key market players are focusing on strengthening their presence and offerings in China—a key factor driving market growth153
TABLE 151CHINA: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION)154
TABLE 152CHINA: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)154
TABLE 153CHINA: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)155
TABLE 154CHINA: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION)155
TABLE 155CHINA: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)156
10.4.2JAPAN156
10.4.2.1Rising use of metagenomic sequencing for various applications to drive market growth in Japan156
TABLE 156JAPAN: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION)157
TABLE 157JAPAN: METAGENOMIC SEQUENCING MARKET, BY PRODUCT &
SERVICE, 2020–2027 (USD MILLION)157
TABLE 158JAPAN: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)158
TABLE 159JAPAN: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION)158
TABLE 160JAPAN: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)159
10.4.3INDIA159
10.4.3.1Increasing adoption of strategies such as collaborations and partnerships by various private and government bodies to drive market growth159
TABLE 161INDIA: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION)160
TABLE 162INDIA: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)160
TABLE 163INDIA: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)161
TABLE 164INDIA: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION)161
TABLE 165INDIA: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)162
10.4.4REST OF ASIA PACIFIC162
TABLE 166ROAPAC: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION)163
TABLE 167ROAPAC: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)163
TABLE 168ROAPAC: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)163
TABLE 169ROAPAC: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION)164
TABLE 170ROAPAC: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)164
10.4.5LATIN AMERICA164
10.4.5.1Introduction of low-cost sequencing technologies is expected to drive the market164
TABLE 171LATAM: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION)165
TABLE 172LATAM: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)165
TABLE 173LATAM: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)166
TABLE 174LATAM: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION)166
TABLE 175LATAM: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)167
10.4.6MIDDLE EAST & AFRICA167
10.4.6.1Rising awareness of advanced sequencing technologies is expected to drive market growth in the coming years167
TABLE 176MEA: METAGENOMIC SEQUENCING MARKET, BY WORKFLOW,
2020–2027 (USD MILLION)167
TABLE 177MEA: METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)168
TABLE 178MEA: METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION)168
TABLE 179MEA: METAGENOMIC SEQUENCING MARKET, BY APPLICATION,
2020–2027 (USD MILLION)169
TABLE 180MEA: METAGENOMIC SEQUENCING MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)169
11COMPETITIVE LANDSCAPE170
11.1KEY PLAYER STRATEGIES170
FIGURE 28OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN THE METAGENOMIC SEQUENCING MARKET171
11.2MARKET SHARE ANALYSIS172
FIGURE 29METAGENOMIC SEQUENCING MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS, 2020172
TABLE 181METAGENOMIC SEQUENCING MARKET: DEGREE OF COMPETITION172
11.3REVENUE ANALYSIS173
FIGURE 30REVENUE ANALYSIS FOR KEY COMPANIES (2018-2021)173
11.4COMPANY EVALUATION QUADRANT174
FIGURE 31METAGENOMIC SEQUENCING MARKET: COMPANY EVALUATION MATRIX, 2021174
11.4.1STARS175
11.4.2PERVASIVE PLAYERS175
11.4.3EMERGING LEADERS175
11.4.4PARTICIPANTS175
11.5COMPETITIVE LEADERSHIP MAPPING (START-UPS)176
FIGURE 32METAGENOMIC SEQUENCING MARKET: COMPANY EVALUATION MATRIX FOR START-UPS, 2021176
11.5.1PROGRESSIVE COMPANIES177
11.5.2STARTING BLOCKS177
11.5.3DYNAMIC COMPANIES177
11.5.4RESPONSIVE COMPANIES177
11.6COMPETITIVE BENCHMARKING177
TABLE 182COMPANY PRODUCT FOOTPRINT (25 COMPANIES)177
TABLE 183COMPANY REGION FOOTPRINT (25 COMPANIES)178
11.7COMPETITIVE SCENARIO179
11.7.1PRODUCT LAUNCHES179
TABLE 184METAGENOMIC SEQUENCING MARKET: PRODUCT LAUNCHES,
JANUARY 2018-FEBRUARY 2022179
11.7.2DEALS180
TABLE 185METAGENOMIC SEQUENCING MARKET: DEALS,
JANUARY 2018-FEBRUARY 2022180
11.7.3OTHER DEVELOPMENTS181
TABLE 186METAGENOMIC SEQUENCING MARKET: OTHER DEVELOPMENTS,
JANUARY 2018-FEBRUARY 2022181
12COMPANY PROFILES182
12.1MAJOR PLAYERS182
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1ILLUMINA, INC.182
TABLE 187ILLUMINA, INC.: BUSINESS OVERVIEW182
FIGURE 33ILLUMINA, INC.: COMPANY SNAPSHOT (2021)183
12.1.2THERMO FISHER SCIENTIFIC, INC.188
TABLE 188THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW188
FIGURE 34THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021)189
12.1.3QIAGEN N.V.194
TABLE 189QIAGEN N.V.: BUSINESS OVERVIEW194
FIGURE 35QIAGEN N.V.: COMPANY SNAPSHOT (2020)195
12.1.4PERKINELMER, INC.200
TABLE 190PERKINELMER, INC.: BUSINESS OVERVIEW200
FIGURE 36PERKINELMER, INC.: COMPANY SNAPSHOT (2021)201
12.1.5OXFORD NANOPORE TECHNOLOGIES, PLC.204
TABLE 191OXFORD NANOPORE TECHNOLOGIES, PLC.: BUSINESS OVERVIEW204
12.1.6PACIFIC BIOSCIENCES OF CALIFORNIA, INC.207
TABLE 192PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: BUSINESS OVERVIEW207
FIGURE 37PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: COMPANY SNAPSHOT (2020)208
12.1.7BGI GROUP212
TABLE 193BGI GROUP: BUSINESS OVERVIEW212
12.1.8PSOMAGEN, INC.215
TABLE 194PSOMAGEN, INC.: BUSINESS OVERVIEW215
12.1.9EUROFINS SCIENTIFIC217
TABLE 195EUROFINS SCIENTIFIC: BUSINESS OVERVIEW217
FIGURE 38EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2020)218
12.1.10BROOKS AUTOMATION, INC.220
TABLE 196BROOKS AUTOMATION, INC.: BUSINESS OVERVIEW220
FIGURE 39BROOKS AUTOMATION, INC.: COMPANY SNAPSHOT (2020)221
12.1.11NOVOGENE CO., LTD.223
TABLE 197NOVOGENE CO., LTD.: BUSINESS OVERVIEW223
12.1.12ZYMO RESEARCH CORPORATION225
TABLE 198ZYMO RESEARCH CORPORATION: BUSINESS OVERVIEW225
12.1.13TECAN TRADING AG227
TABLE 199TECAN TRADING AG: BUSINESS OVERVIEW227
FIGURE 40TECAN TRADING AG: COMPANY SNAPSHOT (2020)228
12.1.14INTEGRAGEN SA230
TABLE 200INTEGRAGEN SA: BUSINESS OVERVIEW230
FIGURE 41INTEGRAGEN SA: COMPANY SNAPSHOT (2020)230
12.1.15MICROSYNTH AG232
TABLE 201MICROSYNTH AG: BUSINESS OVERVIEW232
12.1.16DNASTAR, INC.234
TABLE 202DNASTAR: BUSINESS OVERVIEW234
12.2OTHER COMPANIES235
12.2.1COSMOSID, INC.235
TABLE 203COSMOSID, INC.: COMPANY OVERVIEW235
12.2.2GENEXA AG236
TABLE 204GENEXA AG.: COMPANY OVERVIEW236
12.2.3VARIGEN BIOSCIENCES CORPORATION236
TABLE 205VARIGEN BIOSCIENCES: COMPANY OVERVIEW236
12.2.4VERITAS GENETICS237
TABLE 206VERITAS GENETICS: COMPANY OVERVIEW237
12.2.5SINGENE237
TABLE 207SINGENE: COMPANY OVERVIEW237
12.2.6METAGENOMI238
TABLE 208METAGENOMI: COMPANY OVERVIEW238
12.2.7COMPUTOMICS238
TABLE 209COMPUTOMICS: COMPANY OVERVIEW238
12.2.8IDBYDNA, INC.239
TABLE 210IDBYDNA, INC.: COMPANY OVERVIEW239
12.2.9INTACT GENOMICS, INC.239
TAB

Report Title: Metagenomic Sequencing Market by Product & Services (Reagent, Consumables, Instrument), Workflow (Sample Preparation, Sequencing), Technology (16S rRNA, Shotgun, Whole-genome), Application (Drug Discovery, Diagnostic) - Global Forecast to 2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

US Transdermal Patch Market Opportunity & Clinical Trials Insight 2028

US Transdermal Patch Market Opportunity & Clinical Trials Insight 2028

Asia Pacific Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

Asia Pacific Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

Europe Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

Europe Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

North America Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

North America Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

Global Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Region: Trend Forecast and Growth Opportunity

Global Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Region: Trend Forecast and Growth Opportunity

Asia Pacific Rehabilitation Equipment Market 2021-2031 by Product (Daily Living Aids, Exercise Equipment, Body Support Devices, Mobility Equipment), Application (Physiotherapy, Occupational Therapy, Others), End User (Hospitals & Clinics, Rehab Centers, Homecare Settings, Physiotherapy Centers, Others), and Country: Trend Forecast and Growth Opportunity

Asia Pacific Rehabilitation Equipment Market 2021-2031 by Product (Daily Living Aids, Exercise Equipment, Body Support Devices, Mobility Equipment), Application (Physiotherapy, Occupational Therapy, Others), End User (Hospitals & Clinics, Rehab Centers, Homecare Settings, Physiotherapy Centers, Others), and Country: Trend Forecast and Growth Opportunity